Kathi Niffenegger - Feb 28, 2022 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
Chief Financial Officer
Signature
/s/ Kathi Niffenegger
Stock symbol
EDSA
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/7/2022, 06:40 PM
Next filing
Nov 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDSA Stock Option (right to buy) Award $0 +43.5K $0.00 43.5K Feb 28, 2022 Common Shares 43.5K $3.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests monthly in equal proportions over 36 months beginning on the Grant Date.